| Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. (NCT03059160) | Sheba Medical Center | 2017-04-01 |
| Pasireotide in Hyperinsulinemic Hypoglycemia (NCT03053284) | Montefiore Medical Center | 2017-04-01 |
| Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma (NCT03180476) | Sichuan Cancer Hospital and Research Institute | 2017-04-01 |
| Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis? (NCT02908490) | Kimberly Liang | 2017-04-01 |
| The Vaginal Progesterone and Cerclage (NCT02846909) | Assiut University | 2017-04-01 |
| Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT03053102) | Alexion Pharmaceuticals, Inc. | 2017-03-31 |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (NCT03242382) | Grupo Espanol de Investigacion en Sarcomas | 2017-03-31 |
| A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients (NCT03102398) | Tritech Biopharmaceuticals Co., Ltd. | 2017-03-31 |
| Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma (NCT03097939) | National Cancer Centre, Singapore | 2017-03-31 |
| ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. (NCT02933801) | Swiss Cancer Institute | 2017-03-31 |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer (NCT03012100) | Academic and Community Cancer Research United | 2017-03-31 |
| A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults (NCT02935686) | Janssen Vaccines & Prevention B.V. | 2017-03-31 |
| Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (NCT02966353) | Novartis Pharmaceuticals | 2017-03-31 |
| PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery (NCT03131336) | Haemostatix Ltd | 2017-03-31 |
| Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure (NCT03027375) | Beijing University of Chinese Medicine | 2017-03-31 |
| Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients (NCT03077048) | Fresenius Kabi | 2017-03-30 |
| Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (NCT03114683) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-03-30 |
| Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer (NCT02849496) | National Cancer Institute (NCI) | 2017-03-30 |
| RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours (NCT03199872) | RhoVac APS | 2017-03-30 |
| Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity (NCT02873819) | Gliknik Inc. | 2017-03-30 |
| Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) (NCT02911116) | National Eye Institute (NEI) | 2017-03-30 |
| A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy (NCT02612155) | Michael Cotten | 2017-03-30 |
| Efficacy Of A PVP-I Fluoride Varnish (NCT03082196) | Advantage Dental Services, LLC | 2017-03-30 |
| Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) (NCT03149445) | Saniona | 2017-03-30 |
| A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer (NCT03026166) | AbbVie | 2017-03-30 |
| A Study of JR-141 in Patients With Mucopolysaccharidosis Type II (NCT03128593) | JCR Pharmaceuticals Co., Ltd. | 2017-03-30 |
| Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily (NCT03067415) | Chong Kun Dang Pharmaceutical | 2017-03-30 |
| Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer (NCT02865135) | Dana-Farber Cancer Institute | 2017-03-30 |
| Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators (NCT03152175) | Douglas Mental Health University Institute | 2017-03-30 |
| Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis (NCT02745184) | Shanghai East Hospital | 2017-03-30 |
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors (NCT02988843) | Masonic Cancer Center, University of Minnesota | 2017-03-29 |
| Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer (NCT02963610) | Fox Chase Cancer Center | 2017-03-29 |
| Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea (NCT03050086) | BioPharmX, Inc. | 2017-03-29 |
| High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies (NCT03146962) | Weill Medical College of Cornell University | 2017-03-29 |
| VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (NCT03110770) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-29 |
| An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) (NCT03001882) | Bristol-Myers Squibb | 2017-03-29 |
| A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients (NCT03309800) | Hanlim Pharm. Co., Ltd. | 2017-03-29 |
| An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults (NCT03094429) | SyneuRx International (Taiwan) Corp | 2017-03-29 |
| Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma (NCT03117751) | St. Jude Children's Research Hospital | 2017-03-29 |
| Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults (NCT02261519) | SyneuRx International (Taiwan) Corp | 2017-03-29 |
| Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia (NCT03027609) | Aridis Pharmaceuticals, Inc. | 2017-03-29 |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer (NCT03026140) | The Netherlands Cancer Institute | 2017-03-29 |
| Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial (NCT03066258) | REGENXBIO Inc. | 2017-03-29 |
| Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC (NCT03057106) | Canadian Cancer Trials Group | 2017-03-28 |
| Phase II Study of Single Agent Lenvatinib (NCT03168074) | National University Hospital, Singapore | 2017-03-28 |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia (NCT03019939) | M.D. Anderson Cancer Center | 2017-03-28 |
| Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer (NCT02788981) | University of Chicago | 2017-03-28 |
| A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment (NCT02927769) | Bristol-Myers Squibb | 2017-03-28 |
| Fecal Transplant for Crohn's Disease (NCT03078803) | University of Alberta | 2017-03-28 |
| Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a) (NCT02890953) | Samsung Medical Center | 2017-03-28 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03082534) | University of California, San Diego | 2017-03-28 |
| Laparoscopic Total Gastrectomy With Versus Without Bursectomy (NCT03117283) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2017-03-28 |
| Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study (NCT02932007) | University of South Florida | 2017-03-28 |
| Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma (NCT02788201) | National Cancer Institute (NCI) | 2017-03-27 |
| Fecal Microbiota Transplantation in Ulcerative Colitis (NCT03273465) | Assaf-Harofeh Medical Center | 2017-03-27 |
| Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL (NCT03259529) | St. Petersburg State Pavlov Medical University | 2017-03-27 |
| Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) (NCT03059797) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-03-27 |
| Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin (NCT02883556) | Assistance Publique - Hôpitaux de Paris | 2017-03-27 |
| Derma-Stent Novel Abscess Packing Device (NCT03171714) | Aaron Brody, MD, MPH | 2017-03-27 |
| Vitamin B12 Supplementation During Pregnancy on Cognitive Development (NCT03071666) | Centre For International Health | 2017-03-27 |
| Partnership for Research on Ebola VACcinations (NCT02876328) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-27 |
| Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne (NCT03076320) | University of Guadalajara | 2017-03-27 |
| A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults (NCT02990325) | Abivax S.A. | 2017-03-27 |
| A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) (NCT02985957) | Bristol-Myers Squibb | 2017-03-26 |
| A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis (NCT03089229) | Haus Bioceuticals | 2017-03-26 |
| Manipulating the Gut Microbiome Study (NCT03181828) | Nicholas Ah Mew | 2017-03-24 |
| Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck (NCT03132038) | UNICANCER | 2017-03-24 |
| Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT03118765) | Glenmark Specialty S.A. | 2017-03-24 |
| Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA (NCT03033680) | Brigham and Women's Hospital | 2017-03-24 |
| Use of Pancreatic Enzymes in Short Bowel Syndrome (NCT03097029) | Children's Hospital of Philadelphia | 2017-03-24 |
| A Study to Evaluate SAGE-217 in Participants With Essential Tremor (NCT02978781) | Biogen | 2017-03-24 |
| Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT02949219) | Academic and Community Cancer Research United | 2017-03-24 |
| Ramelteon in the Prevention of Post-operative Delirium (NCT02324153) | Johns Hopkins University | 2017-03-24 |
| Functional Connectivity as a Biomarker of rTMS (NCT03050801) | National Institute of Neurological Disorders and Stroke (NINDS) | 2017-03-24 |
| Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I) (NCT04439227) | National Cancer Institute (NCI) | 2017-03-24 |
| Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck (NCT02979977) | Yale University | 2017-03-24 |
| Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ Damage (NCT03088514) | Queen Mary University of London | 2017-03-23 |
| Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer (NCT02984683) | Sanofi | 2017-03-23 |
| Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J) (NCT06136897) | National Cancer Institute (NCI) | 2017-03-23 |
| To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors (NCT02977065) | Chong Kun Dang Pharmaceutical | 2017-03-23 |
| Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment (NCT03224221) | The First Affiliated Hospital of Anhui Medical University | 2017-03-23 |
| A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) (NCT02727699) | Actinogen Medical | 2017-03-23 |
| Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency (NCT03114020) | Gerard Turino | 2017-03-22 |
| Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C) (NCT06390839) | National Cancer Institute (NCI) | 2017-03-22 |
| Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC (NCT03136627) | AVEO Pharmaceuticals, Inc. | 2017-03-22 |
| Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease (NCT03036852) | Gilead Sciences | 2017-03-22 |
| A Study of AV0328 Administered to Healthy Adult Volunteers (NCT02853617) | Alopexx Vaccine, LLC | 2017-03-22 |
| A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer (NCT03051659) | Dana-Farber Cancer Institute | 2017-03-22 |
| Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma (NCT03167385) | Tianjin Medical University Cancer Institute and Hospital | 2017-03-22 |
| POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST (NCT03171389) | Sebastian Bauer | 2017-03-22 |
| A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer (NCT03093922) | Memorial Sloan Kettering Cancer Center | 2017-03-22 |
| The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo (NCT03090087) | University of Aarhus | 2017-03-22 |
| Remote Brief Intervention and Referrals to Treatment Service for Alcohol (NCT02622984) | Polaris Health Directions | 2017-03-22 |
| Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder (NCT02900976) | Children's Oncology Group | 2017-03-22 |
| Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma (NCT04063189) | The First Hospital of Jilin University | 2017-03-21 |
| A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy (NCT02994147) | TWi Biotechnology, Inc. | 2017-03-21 |
| Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma (NCT02748564) | Rutgers, The State University of New Jersey | 2017-03-21 |
| Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System (NCT03067051) | SpectraCure AB | 2017-03-21 |
| Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis (NCT03055195) | GlaxoSmithKline | 2017-03-21 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008) (NCT02987972) | Merck Sharp & Dohme LLC | 2017-03-21 |